Latest Board Renewal News

ALS Limited (ASX:ALQ) has delivered a landmark FY26 with underlying net profit after tax surging 25.8% to $381.2 million, beating 2027 targets a year early and raising its dividend by 10%. The company continues to invest heavily in automation, digital initiatives, and laboratory expansions while advancing its climate strategy amid a post-year-end cyber incident.

Terra Metals appoints Debra Bakker as Chair alongside Jeff Quartermaine and Jennifer Purdie to steer the company’s shift from exploration to development at its promising Dante Project in Western Australia.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Plenti Group Limited (ASX:PLT) has smashed its $3 billion loan portfolio target two months ahead of schedule, delivering a 117% surge in cash profit before tax to $30.8 million for FY26. The fintech lender’s growth was fuelled by record loan originations, robust credit performance, and strategic technology investments.

oOh!media posts solid early 2026 revenue growth and launches a $12 million annual savings program, while exiting retail media and navigating takeover bids.

Altech Batteries has decided to discontinue its Silumina AnodesTM project after six years, shifting full focus to its CERENERGY® solid-state battery technology amid ongoing joint venture talks.

Altech Batteries has won conditional approval for a €46.11 million German government grant supporting its CERENERGY® Sodium-Chloride Solid-State battery project, while shifting its Silumina AnodesTM R&D operations to Germany to enhance efficiency and cut costs.

Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.

Manhattan Gold Corporation has secured A$3 million to kick off a 4,000m reverse circulation drilling program at its Hook Lake Project in Nunavut, Canada, while expanding its exploration area by 81km² with new mineral claims covering high-grade gold anomalies.

Praemium Limited lifted its total Funds Under Administration by 18% to $73.7 billion in Q3 FY26, driven by strong net inflows and growth in its non-custodial portfolio administration. The ongoing integration of Technotia is set to deliver $9 million in annual technology salary savings from FY27.

Xenora Minerals has committed to the next stage of its Dudley Lithium Project earn-in, revealing new lithium anomalies using enhanced soil sampling techniques. Meanwhile, the company navigates a key leadership change with a new managing director appointed.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.